New drug approvals in 2000
Wynn, R.L.
General Dentistry 49(4): 341-345
2001
ISSN/ISBN: 0363-6771 PMID: 12016673 Document Number: 536364
Document emailed within 1 workday
Related Documents
Cima, G. 2015: FDA offers aid toward antiparasitic drug approvals Journal of the American Veterinary Medical Association 247(10): 1085Gatty, B. 1993: Whatever happened to user fees and the FDA's promise to expedite new drug approvals? Hospital Formulary 28(7): 656 655
McGinnis, T.J. 2001: Significant FDA approvals in 2000 American Family Physician 63(10): 2061-2064
Rheinstein, P.H. 1995: Significant FDA approvals in 1994 American Family Physician 51(4): 888-890
Wagner, M. 1992: FDA approvals 'paralyzed'--Dingell Modern Healthcare 22(37): 68
Rheinstein, P.H. 1995: Significant FDA approvals in 1994 American Family Physician 51(4): 888-890
Hensley, S. 1997: Change coming to FDA. Law should speed approvals, but critics say it's not enough Modern Healthcare 27(46): 28
Gloyd, J.S. 1992: New criteria proposed for poison antidote approvals, uses Journal of the American Veterinary Medical Association 201(1): 25-26
Pallarito, K. 1994: 'Radical' new covenants would slash number of HUD project approvals Modern Healthcare 24(44): 28
Miller, H.I. 2019: FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues Missouri Medicine 116(3): 168-169
Juskevich, J.C. 1987: Potential applications of pharmacokinetics toward minor species-use approvals: human food safety Veterinary and Human Toxicology 29(Suppl 1): 89-92
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Jackevicius, C.A.; Tu, K.; Filate, W.A.; Brien, S.E.; Tu, J.V. 2003: Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001 Canadian Journal of Cardiology 19(12): 1359-1366
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035